Millie
your market intelligence analyst
Search Results
534 results
Your search is now limited to «Cancer Drugs» expert search.
ENDPOINTS 09/18/2019 07:10
Australia and Canada previously worked together to approve two other cancer drugs — Eli Lilly’s Verzenio (abemaciclib) in April for the treatment of metastatic breast cancer and the July 2018 approval for Janssen’s prostate cancer treatment apalutamide.
More from ENDPOINTS:
PubMed News (NIH) 09/18/2019
Contributors : Matthew N Davies ; Marco Gerlinger Series Type : Genome variation profiling by SNP array Organism : Homo sapiens. Gastro-esophageal adenocarcinomas (GEAs) are aggressive cancers and multiple trials of targeted therapies recently failed to improve survival in these tumors.
More from PubMed News (NIH):
PR Newswire 09/17/2019 20:29
Prostate cancer is more difficult to treat once it spreads, and for patients with castration-sensitive disease, it is clear that androgen deprivation therapy (ADT) alone, is often not enough," said Dr. Kim Chi , Medical Oncologist at BC Cancer - Vancouver and principal investigator of the TITAN study ...
More from PR Newswire:
Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy.
More from International Journal of COPD:
Seeking Alpha 09/17/2019 10:15
In cooperation, these pathways allow the tumor to persist, execute metastasis, and growing resistance to cancer drugs (Figure 3.
More from Seeking Alpha:
Medindia.com 09/17/2019 08:24
Every year around 6,000 people in the UK are diagnosed with either PV or ET, related blood cancers that cause an overproduction of red blood cells (PV) or blood-clotting platelets (ET.
More from Medindia.com:
ecancer news 09/17/2019 07:12
Although initial experiments showed the drug worked in a variety of cancer cell lines, including melanoma, lymphoma, pancreatic, prostate, lung, colon and breast cancer, TRAIL and similar drugs surprised researchers by showing limited success in clinical trials.
More from ecancer news:
pharmaphorum 09/17/2019 04:36
The US regulator is considering use of the Nectin-4-targeting ADC as treatment for advanced urothelial carcinoma (UC) – the most common form of bladder cancer – after the failure of chemotherapy and cancer immunotherapy.
More from pharmaphorum:
BioPharma Dive 09/16/2019 11:40
But the advantage in immuno-oncology has now decidedly swung to Merck & Co.'s Keytruda plus chemotherapy in previously untreated non-small cell lung cancer.
More from BioPharma Dive:
But a third lung cancer drug, osimertinib, has been rejected by the SMC as it was deemed to not provide enough value for money.
More from Medical Xpress - Medications News:
GlobeNewswire 09/16/2019 09:00
The other paper addresses the use of devimistat for the treatment of acute myeloid leukemia (AML), authored by Dr. Jorge Cortes, director of the Georgia Cancer Center at Augusta University.
More from GlobeNewswire:
Benzinga 09/16/2019 08:05
This pipeline is led by AU-409, which is being developed for the treatment of hepatocellular carcinoma.
More from Benzinga:
Reuters.com 09/13/2019 12:25
The European Medicines Agency said it will also start a review of the over-the-counter heartburn drug.
More from Reuters.com:
News-Medical.net 09/13/2019 12:09
The target proteins had no effect on cancer growth As reported in the journal Science Translational Medicine, each of the proteins that the drugs targeted had no effect on cancer cells cultured in the laboratory.
More from News-Medical.net:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications